Gene expression profiles in human mesothelioma cell lines in response to interferon-γ treatment

Cancer Genetics and Cytogenetics

Volumn 152, Issue 1, 2004, Pages 42-51

  Kettunen, Eeva ^a   Vivo, Claire ^b   Gattacceca, Florence ^b   Knuutila, Sakari ^a   Jaurand, Marie Claude ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; JANUS KINASE; STAT PROTEIN;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UNINDEXED SEQUENCE;

ANTINEOPLASTIC AGENTS; CELL DIVISION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON TYPE II; MESOTHELIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 2942537902     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.10.006     Document Type: Article

References (40)

1. Lee Y.C., Light R.W., Musk A.W. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med. 6:2000;267-274
2. Pass H.I., Robinson B.W., Testa J.R., Carbone M. Emerging translational therapies for mesothelioma. Chest. 116:(6 Suppl):1999;455S-460S
3. Nowak A.K., Lake R.A., Kindler H.L., Robinson B.W. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol. 29:2002;82-96
4. Boutin C., Nussbaum E., Monnet I., Bignon J., Vanderschueren R., Guerin J.C., Menard O., Mignot P., Dabouis G., Douillard J.Y. Intrapleural treatment with recombinant γ-interferon in early stage malignant pleural mesothelioma. Cancer. 74:1994;2460-2467
5. Hand A.M., Husgafvel-Pursiainen K., Tammilehto L., Mattson K., Linnainmaa K. Malignant mesothelioma: the antiproliferative effect of cytokine combinations on three human mesothelioma cell lines. Cancer Lett. 58:1991;205-210
6. Hand A.M., Husgafvel-Pursiainen K., Pelin K., Vallas M., Suitiala T., Ekman A., Mattson M., Mattson K., Linnainmaa K. Interferon-α and -γ in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines. Anticancer Drugs. 3:1992;687-694
7. Hand A., Pelin K., Mattson K., Linnainmaa K. Interferon (IFN)-α and IFN-γ in combination with methotrexate: in vitro sensitivity studies in four human mesothelioma cell lines. Anticancer Drugs. 6:1995;77-82
8. Phan-Bich L., Buard A., Petit J.F., Zeng L., Tenu J.P., Chretien P., Monnet I., Boutin C., Bignon J., Lemaire G., Jaurand M.C. Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-γ Am J Respir Cell Mol Biol. 16:1997;178-186
9. Zeng L., Buard A., Monnet I., Boutin C., Fleury J., Saint-Etienne L., Brochard P., Bignon J., Jaurand M.C. In vitro effects of recombinant human interferon γ on human mesothelioma cell lines. Int J Cancer. 55:1993;515-520
10. Billiau A. Interferon-γ: biology and role in pathogenesis. Adv Immunol. 62:1996;61-130
11. Kimchi A. Cytokine triggered molecular pathways that control cell cycle arrest. J Cell Biochem. 50:1992;1-9
12. Buard A., Vivo C., Monnet I., Boutin C., Pilatte Y., Jaurand M.C. Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1α for inhibition by interferon-γ Cancer Res. 58:1998;840-847
13. Ramana C.V., Gil M.P., Han Y., Ransohoff R.M., Schreiber R.D., Stark G.R. Stat1-independent regulation of gene expression in response to IFN-γ Proc Natl Acad Sci U S A. 98:2001;6674-6679
14. Ramana C., Gil M., Schreiber R., Stark G. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23:2002;96-101
15. Aberger F., Costa-Pereira A.P., Schlaak J.F., Williams T.M., O'Shaughnessy R.F., Hollaus G., Kerr I.M., Frischauf A.M. Analysis of gene expression using high-density and IFN-γ-specific low-density cDNA arrays. Genomics. 77:2001;50-57
16. Vivo C., Lévy F., Pilatte Y., Fleury-Feith J., Chrétien P., Monnet I., Kheuang L., Jaurand M.C. Control of cell cycle progression in human mesothelioma cells treated with γ interferon. Oncogene. 20:2001;1085-1093
17. Boehm U., Klamp T., Groot M., Howard J.C. 1997. A list of genes regulated by IFN-γ [Internet]. Available from http://arjournals.annualreviews.org/ doi/suppl/10.1146/annurev.immunol.15.1.749. Supplemental material to Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol. 15:1997;749-795
18. Boehm U., Guethlein L., Klamp T., Ozbek K., Schaub A., Futterer A., Pfeffer K., Howard J.C. Two families of GTPases dominate the complex cellular response to IFN-γ J Immunol. 161:1998;6715-6723
19. Der S.D., Zhou A., Williams B.R.G., Silverman R.H. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc Natl Acad Sci U S A. 95:1998;15623-15628
20. Rajeevan M.S., Vernon S.D., Taysavang N., Unger E.R. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn. 3:2001;26-31
21. Willert K., Nusse R. β-Catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev. 8:1998;95-102
22. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-γ Annu Rev Immunol. 15:1997;749-795
23. Gattacceca F., Pilatte Y., Billard C., Monnet I., Moritz S., Le Carrou J., Eloit M., Jaurand M.C. Ad-IFNγ induces antiproliferative and antitumoral responses in malignant mesothelioma. Clin Cancer Res. 8:2002;3298-3304
24. Castor C.W., Miller J.W., Walz D.A. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc Natl Acad Sci U S A. 80:1983;765-769
25. Castor C.W., Furlong A.M., Carter-Su C. Connective tissue activation: stimulation of glucose transport by connective tissue activating peptide III. Biochemistry. 24:1985;1762-1767
26. Iida N., Haisa M., Igarashi A., Pencev D., Grotendorst G.R. Leukocyte-derived growth factor links the PDGF and CXC chemokine families of peptides. FASEB J. 10:1996;1336-1345
27. Visser C.E., Tekstra J., Brouwer-Steenbergen J.J., Tuk C.W., Boorsma D.M., Sampat-Sardjoepersad S.C., Meijer S., Krediet R.T., Beelen R.H. Chemokines produced by mesothelial cells: huGRO-α, IP-10, MCP-1 and RANTES. Clin Exp Immunol. 112:1998;270-275
28. Robson R.L., McLoughlin R.M., Witowski J., Loetscher P., Wilkinson T.S., Jones S.A., Topley N. Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-γ controls neutrophil migration across the mesothelium in vitro and in vivo. J Immunol. 167:2001;1028-1038
29. Fulda S., Debatin K.M. IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene. 21:2002;2295-2308
30. Liu W., Bodle E., Chen J.Y., Gao M., Rosen G.D., Broaddus V.C. Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines. Am J Respir Cell Mol Biol. 25:2001;111-118
31. Smith M.R., Wilson M.L., Hamanaka R., Chase D., Kung H., Longo D.L., Ferris D.K. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun. 234:1997;397-405
32. Härkönen E., Virtanen I., Linnala A., Laitinen L.L., Kinnula V.L. Modulation of fibronectin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. Am J Respir Cell Mol Biol. 13:1995;109-115
33. Czaja M.J., Weiner F.R., Eghbali M., Giambrone M.A., Eghbali M., Zern M.A. Differential effects of γ-interferon on collagen and fibronectin gene expression. J Biol Chem. 262:1987;13348-13351
34. König J.E., Tolnay E., Wiethege T., Müller K.M. Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma. Virchows Arch. 435:1999;8-12
35. Strizzi L., Catalano A., Vianale G., Orecchia S., Casalini A., Tassi G., Puntoni R., Mutti L., Procopio A. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol. 193:2001;468-475
36. Hotfilder M., Knupfer H., Mohlenkamp G., Pennekamp P., Knupfers M., Van Gool S., Wolff J.E. Interferon-γ increases IL-6 production in human glioblastoma cell lines. Anticancer Res. 20:2000;4445-4450
37. Bölling B., Fandrey J., Frosch P.J., Acker H. VEGF production, cell proliferation and apoptosis of human IGR 1 melanoma cells under nIFN-α/β and rIFN-γ treatment. Exp Dermatol. 9:2000;327-335
38. Koyama S., Sato E., Tsukadaira A., Haniuda M., Numanami H., Kurai M., Nagai S., Izumi T. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J. 20:2002;1449-1456
39. Ohta Y., Shridhar V., Bright R.K., Kalemkerian G.P., Du W., Carbone M., Watanabe Y., Pass H.I. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer. 81:1999;54-61
40. Churchill G.A. Fundamentals of experimental design for cDNA microarrays. Nat Genet. 32:(Suppl):2002;490-495